Bronchiolitis Disease

BASICS

DESCRIPTION
Inflammation of the bronchioles, usually seen in young children, occasionally in high-risk adults. May be seasonal (winter and spring) and often occurs in epidemics. Usual course: insidious; acute; progressive.
  • System(s) affected: Pulmonary
  • Genetics: N/A
  • Incidence/Prevalence in USA: Medical care provided to 1000-1500/100,000 annually. Estimated incidence is higher.
  • Predominant age: newborn-2 years (peak age 2-6 months)
  • Predominant sex: Male > Female
SIGNS AND SYMPTOMS
  • Anorexia
  • Cough
  • Cyanosis
  • Expiratory wheezing
  • Apnea
  • Fever
  • Grunting
  • Inspiratory crackles
  • Intercostal retractions
  • Noisy breathing
  • Otitis media
  • Pharyngitis
  • Tachycardia
  • Tachypnea
  • Vomiting
CAUSES
  • Respiratory syncytial virus
  • Parainfluenza
  • Adenovirus
  • Rhinovirus
  • Influenza virus
  • Chlamydia
  • Eye, nose, mouth inoculation
  • Exposure to adult with URI
  • Day care exposure (significant)
  • Idiopathic (many adult cases)
RISK FACTORS
  • Contact with infected person
  • Children in day care environment
  • Heart-lung transplantation patient
  • Adults - exposure to toxic fumes, connective tissue disease

DIAGNOSIS

LABORATORY
  • Arterial blood gas - hypoxemia, hypercarbia, acidemia
  • Respiratory viral culture - positive
  • Respiratory viral antigens - positive

Drugs that may alter lab results: N/A
Disorders that may alter lab results: N/A

PATHOLOGICAL FINDINGS
  • Abundant mucous exudate
  • Mucosal - hyperemia, edema
  • Submucosal lymphocytic infiltrate, monocytic infiltrate, plasmacytic infiltrate
  • Small airway debris, fibrin, inflammatory exudate, fibrosis
  • Peribronchiolar mononuclear infiltrate
SPECIAL TESTS
Infant pulmonary function studies - bronchodilator response
IMAGING
  • Chest x-ray
    • Focal atelectasis
    • Air trapping
    • Flattened diaphragm
    • Increased anteroposterior diameter
    • Peribronchial cuffing
DIAGNOSTIC PROCEDURES
N/A

TREATMENT

APPROPRIATE HEALTH CARE
  • Most patients can be treated at home
  • Inpatient indicated for patient with increased respiratory distress, cyanosis, and dehydration
GENERAL MEASURES
  • Most critical phase is first 48-72 hours after onset. Treatment is usually symptomatic.
  • Fluid at maintenance
  • Mechanical ventilation in respiratory failure
  • Isolation: contact; handwashing most important
  • Antiviral agents for selected high-risk patients
  • Cardio-respiratory monitoring
  • Inhaled bronchodilators are commonly used, although efficacy has been hard to demonstrate in controlled studies
  • Steroids may not change course - except in patients with reactive airway disease
SURGICAL MEASURES

N/A

ACTIVITY
  • Avoid exposure to crowds, viral illness for 2 months
  • Avoid smoke
DIET
  • Frequent small feedings of clear liquids
  • If hospitalized, may require intravenous fluids
PATIENT EDUCATION

Griffith: Instructions for Patients; Philadelphia, W.B. Saunders Co.

FOLLOW UP

PREVENTION/AVOIDANCE
  • Hand washing
  • Contact isolation of infected babies
  • Persons with colds should keep contacts with infants to a minimum
  • ´Palivizumab´ (Synagis), a monoclonal product, can be used for prevention in high-risk patients (28-32 weeks gestation and less than 6 months old; less than 28 weeks gestation and less than 12 months old; moderately severe BRD and up to two years old). Administer monthly (November thru March) 15 mg/kg IM. Single use vial of 100 mg and 50 mg.
  • ´RSV immune globulin´, a human blood product, can also be used in at-risk patients. Monthly infusions of 750 mg/kg, November thru March, in a controlled setting. Avoid fluid overload. Vial is 50 mg/mL; infuse at 1.5-6 mL/kg/hr; monitor oximeter and vital signs.
  • Both of these medications are quite expensive.
POSSIBLE COMPLICATIONS
  • Bacterial superinfection
  • Bronchiolitis obliterans
  • Apnea
  • Respiratory failure
  • Death
  • Increased incidence of RAD
EXPECTED COURSE AND PROGNOSIS
  • In most cases, recovery is complete within 7-10 days
  • Mortality statistics differ, but probably under 1%
  • High-risk infants (BPD, CHD) may have prolonged course

MISCELLANEOUS

ASSOCIATED CONDITIONS
  • Common cold
  • Conjunctivitis
  • Pharyngitis
  • Otitis media
  • Diarrhea
AGE-RELATED FACTORS

Pediatric: Most common in infants
Geriatric: N/A
Others: N/A

PREGNANCY

N/A

OTHER NOTES

N/A

ABBREVIATIONS

BPD = bronchopulmonary dysplasia
CHD = congenital heart disease
RAD = reactive airway disease
SPAG = small particle aerosol generator

Clinical Investigations

ROLE OF HOMOEOPATHY

Copyright © 2025 Selkey. All Rights Reserved.